Nutrichem: Completed the process optimization of the 4,000 t/a Azoxystrobin technical project, and the new catalyst is expected to be put into use this year

On May 7, 2024, Nutrichem held a performance presentation meeting, which was received by Wang Rong, chairman of the listed company, Liu Xiaoliang, secretary of the Board of Directors, financial responsibility, Yang Yusong, and sponsor representative Kong Huihuan. The presentation provided an introduction to the company and its operating results for the year 2023, as well as answers to investor concerns. The main questions and replies are as follows:

Q: May I ask whether the optimization of the process plan will continue in 2024, and How many years will it take for new catalysts to be used?

A: Nutrichem always adheres to the concept of research and development as the basis, and continuously improves the company's product competitiveness and independent innovation ability. During the reporting period, the company's 4,000 t/a of Azoxystrobin technical project has achieved results in terms of process plan and catalyst use, and in 2024, the company's research and development will continue to make efforts in key research projects, and it is expected that new catalysts can be put into use within this year.

Q:As a listed company specializing in the field of pesticide chemistry, what is the layout and planning of biosynthesis

A: Nutrichem uses the research and development platform to continuously carry out the technical transformation of existing products, improve product quality and reduce the emission of three wastes; And continue to develop new products, technical reserves. Planning of using synthetic biology: 1. Using enzyme catalysis technology to solve industrial issues such as hydrolysis and chiral catalysis. 2. Aiming at the cost and efficiency problems of biosynthesis technology, try to combine engineering continuous technology to develop process technology.

Q: What was the company's performance in research and development last year?

A: Since its establishment, the company has been actively responding to policy guidance, continuously consolidating and optimizing the product and technological innovation system, and working together to enhance product competitiveness. During the reporting period, the company completed the optimization of the process plan of the 4,000 t/a Azoxystrobin technical project, and completed the preliminary exploration of the use of new catalysts; The 2-Nitro-4-methylsulfonylbenzoic acid project completed several links of experiment and research, and the pilot work was carried out in an orderly manner. The steady progress of these important research projects will help the company further optimize product quality in the production process, reduce production costs, and achieve the goal of energy conservation and emission reduction.

Q: Have all the 2020 funding projects been put into production?

A: After the Company publicly issues shares to non-specific qualified investors and lists the raised funds in the selected tier and deducts the relevant expenses, it will be used to raise and invest in construction projects in accordance with the provisions of national laws and regulations and regulatory agencies and the needs of the company's business development, and the remaining part will be used to repay bank loans. The company's investment projects focus on the main business, in line with the relevant national industrial policies, the requirements of relevant laws and regulations and the company's business development direction, with good market development prospects and economic benefits. By the end of 2023, 4000t/a Mesotrione and 1000t/a new Oxyfluorfen Standard production capacity projects have been successfully put into operation. For the projects that have not yet been completed, the company has continuously optimized the design of process safety in accordance with relevant requirements, carried out partial re-planning and layout adjustment of the production workshop, and extended the pilot study time to achieve better results. It is expected to be completed by the end of 2024.